Loading...
XWAR
AWM
Market cap8mUSD
Jul 22, Last price  
0.28PLN
1D
-1.61%
1Q
-11.84%
IPO
-85.73%
Name

Airway Medix SA

Chart & performance

D1W1MN
XWAR:AWM chart
P/E
18.16
P/S
7,928.23
EPS
0.02
Div yield, %
Shrs. gr., 5y
9.82%
Rev. gr., 5y
-56.51%
Revenues
4k
-66.67%
00057,0000921,000294,000257,0006,00095,00012,00012,0004,000
Net income
2m
P
-1,826,000-1,826,000-1,519,000-2,016,000635,000-2,034,000-1,361,000-2,374,000-7,044,000-37,914,000-3,276,000-11,735,0001,746,000
CFO
-3m
L-55.44%
-2,007,000-2,007,000-998,000-3,027,000-3,686,000-3,110,0004,983,000-2,248,000-5,853,000-442,000-4,195,000-7,590,000-3,382,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Airway Medix S.A. specializes in the research, development, and market introduction of disposable medical devices. These products are specifically designed for patients on mechanical ventilation in intensive care units and for individuals in critical, life-threatening conditions within anesthesiology departments. Their portfolio includes a Closed Suction System for clearing endotracheal tubes in mechanically ventilated patients, an Oral Care system to maintain oral hygiene for intubated and immobilized individuals, and a Cuff Pressure Regulator for continuous monitoring and consistent pressure management of intubation tube cuffs. The company is headquartered in Warsaw, Poland.
IPO date
May 24, 2016
Employees
8
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT